Reactivation of Chlamydia pneumoniae infection in mice by cortisone treatment

被引:54
|
作者
Laitinen, K
Laurila, AL
Leinonen, M
Saikku, P
机构
[1] NATL PUBL HLTH INST,HELSINKI,FINLAND
[2] NATL PUBL HLTH INST,OULU,FINLAND
关键词
D O I
10.1128/IAI.64.4.1488-1490.1996
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Reactivation of Chlamydia pneumoniae infection was studied by inducing immunosuppression by cortisone acetate treatment given every other day for 14 days in intranasally infected NIH/s mice. The treatment started 2 or 4 weeks after primary infection, when no C. pneumoniae was detected. C. pneumoniae could be recovered from the lung cultures on days 7 and 9 in 10 and 60% of the mice, respectively, when cortisone treatment was begun 30 days after infection. These results confirm the persistent nature of C. pneumoniae infection.
引用
收藏
页码:1488 / 1490
页数:3
相关论文
共 50 条
  • [1] REACTIVATION OF CHLAMYDIA-PNEUMONIAE LUNG INFECTION IN MICE BY CORTISONE
    MALINVERNI, R
    KUO, CC
    CAMPBELL, LA
    GRAYSTON, JT
    JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (02): : 593 - 594
  • [2] REACTIVATION OF CHLAMYDIA-TRACHOMATIS LUNG INFECTION IN MICE BY CORTISONE
    YANG, YS
    KUO, CC
    CHEN, WJ
    INFECTION AND IMMUNITY, 1983, 39 (02) : 655 - 658
  • [3] EXPERIMENTAL-INFECTION OF CHLAMYDIA-PNEUMONIAE IN MICE
    KAUKORANTATOLVANEN, SSE
    LAURILA, AL
    SAIKKU, P
    LEINONEN, M
    LIESIROVA, L
    LAITINEN, K
    MICROBIAL PATHOGENESIS, 1993, 15 (04) : 293 - 302
  • [4] Asthmatic patients with Chlamydia pneumoniae infection and their treatment
    Dokic, D.
    Goseva, Z.
    Trajkovska-Dokic, E.
    Veljanovska, B.
    Arsovski, Z.
    Krkinski, D.
    ALLERGY, 2007, 62 : 187 - 187
  • [5] Chlamydia pneumoniae infection results in generalized bone loss in mice
    Bailey, Leslie
    Engstrom, Patrik
    Nordstrom, Anna
    Bergstrom, Sven
    Waldenstrom, Anders
    Nordstrom, Peter
    MICROBES AND INFECTION, 2008, 10 (10-11) : 1175 - 1181
  • [6] Chlamydia pneumoniae infection enhances microglial activation in atherosclerotic mice
    Voorend, M.
    van der Ven, A. J. A. M.
    Mulder, M.
    Lodder, J.
    Steinbusch, H. W. M.
    Bruggeman, C. A.
    NEUROBIOLOGY OF AGING, 2010, 31 (10) : 1766 - 1773
  • [7] Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice
    Caligiuri, G
    Rottenberg, M
    Nicoletti, A
    Wigzell, H
    Hansson, GK
    CIRCULATION, 2001, 103 (23) : 2834 - 2838
  • [8] TREATMENT OF CHLAMYDIA PNEUMONIAE INFECTION IN PATIENTS WITH ASTHMA.
    Dokic, D.
    Aziri, S.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 107 (05) : A34 - A34
  • [9] Effect of pravastatin treatment on Chlamydia pneumoniae infection, inflammation and serum lipids in NIH/S mice
    Tiirola, Terttu
    Jauhiainen, Matti
    Erkkila, Leena
    Bloigu, Aini
    Leinonen, Maija
    Haasio, Kristiina
    Laitinen, Kirsi
    Saikku, Pekka
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 (06) : 741 - 742
  • [10] Chlamydia pneumoniae infection is not an independent risk factor for development of atherosclerosis in normolipidemic mice and acceleration of the development of lesions in hyperlipidemic mice is unique to Chlamydia pneumoniae
    Blessing, E
    Nagano, S
    Campbell, LA
    Rosenfeld, ME
    Kuo, CC
    CIRCULATION, 2000, 102 (18) : 54 - 54